H.R. 8528
PI Post Acute Access Act
Official summary
Written by the Congressional Research Service.
PI Post Acute Access Act
This bill allows for separate payment under Medicare to skilled nursing facilities for items and services that are needed to administer intravenous immune globin (IVIG) to patients with primary immune deficiency diseases (rare genetic disorders that impair the immune system and increase vulnerability for other infections).
Text of the bill
This Act may be cited as the PI Post Acute Access Act.
(a) In general. Section 1888(e)(2)(A)(iii) of the Social Security Act (42 U.S.C. 1395yy(e)(2)(A)(iii)) is amended by adding at the end the following new subclause:
(VII) Intravenous immune globulin indicated for the treatment of primary immune deficiency disease (identified as of January 1, 2026, by HCPCS codes J1561, J1569, J1576, J1568, J1459, J1554, J1557, J1566, and as subsequently modified by the Secretary) and items and services related to the furnishing of such globulin.
(b) Effective date. The amendment made by subsection (a) shall apply to items and services furnished on or after October 1, 2026.